[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-114-1-medical-surgical-023":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":22},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":10},"nurse-114-1-內外科護理學-023","nurse-114-1-medical-surgical-023",114,1,23,"中樞神經系統癌症病人，若選用難以通過血腦障壁之化學治療時，下列何者為最適切之給藥途徑？ ①Port-A   ②Ommaya reservoir   ③Hickman catheter   ④intrathecal injection",{"A":14,"B":15,"C":16,"D":17},"①③","①④","②③","②④","D",null,[],"本題考點在於中樞神經系統腫瘤化療的給藥途徑選擇。依血腦障壁的藥物通透限制，當化療藥難以穿越血腦障壁時，須改採可直達腦脊髓液的途徑。②Ommaya reservoir為植入頭皮下、導管通入腦室的貯池，可直接注入藥物；④intrathecal injection經腰椎鞘內注射入蜘蛛膜下腔，兩者皆繞過血腦障壁使藥物直達中樞，故選D。①Port-A與③Hickman catheter均為中心靜脈系統的全身性給藥裝置，藥物仍受血腦障壁阻擋，無法有效進入中樞，故排除。",[23,27,31,35,39,43],{"webId":24,"stem":25,"number":10,"year":26,"session":10},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":28,"stem":29,"number":30,"year":26,"session":10},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",2,{"webId":32,"stem":33,"number":34,"year":26,"session":10},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":26,"session":10},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":26,"session":10},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":26,"session":10},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840784110]